Experimental Research Unit, General University Hospital of Albacete, Albacete, Spain.
Cancer Res. 2010 Jan 15;70(2):560-7. doi: 10.1158/0008-5472.CAN-09-3513. Epub 2010 Jan 12.
It has been proposed that cell-free nucleic acids in the plasma participate in tumorigenesis and the development of metastases via transfection-like uptake of such nucleic acids by susceptible cells. This putative phenomenon is tentatively referred to as "genometastasis." In the present study, we examined the effects on cultured cells of plasma from healthy individuals and from patients with colon cancer. Cultures of NIH-3T3 cells and human adipose-derived stem cells (hASC) were supplemented with samples of plasma from patients with K-ras-mutated colorectal tumors or from healthy subjects using two different protocols: direct addition of plasma to cultures in standard plates and addition in the absence of contact between plasma and cells, which were separated by a membrane with 0.4-mum pores. In plasma-treated hASCs, no K-ras-mutated sequences were detected by real-time PCR. In contrast, in most cultures of plasma-treated NIH-3T3 cells (murine cells), the transfer of human DNA occurred, as verified by the detection of human K-ras sequences, p53 sequences, and beta-globin-encoding sequences. Moreover, NIH-3T3 cells that had been cultured with plasma from patients with colon cancer were oncogenically transformed, as shown by the development of carcinomas in nonobese diabetic-severe combined immunodeficient mice after the injection of such cells. Microscopic analysis of membranes that had separated plasma from cultured cells confirmed the complete absence of cells in the plasma. We only observed noncell particles, having diameters of <0.4 mum. Our results indicate that plasma from cancer patients is able to transform cultured cells oncogenically, supporting the previously proposed hypothesis of genometastasis.
有人提出,血浆中的无细胞核酸通过类似转染的方式被易感性细胞摄取,从而参与肿瘤发生和转移的发展。这种假定的现象被暂时称为“基因组转移”。在本研究中,我们检测了来自健康个体和结肠癌患者的血浆对培养细胞的影响。使用两种不同的方案,将来自 K-ras 突变型结直肠肿瘤患者或健康受试者的血浆添加到 NIH-3T3 细胞和人脂肪源性干细胞(hASC)的培养物中:直接将血浆添加到标准平板中的培养物中,以及在没有血浆与细胞接触的情况下添加,血浆与细胞通过 0.4-μm 孔的膜隔开。在血浆处理的 hASC 中,实时 PCR 未检测到 K-ras 突变序列。相比之下,在大多数用血浆处理的 NIH-3T3 细胞(鼠细胞)培养物中,发生了人 DNA 的转移,这通过检测人 K-ras 序列、p53 序列和β-珠蛋白编码序列得到证实。此外,用来自结肠癌患者的血浆培养的 NIH-3T3 细胞发生了致癌转化,这表现在将这些细胞注射到非肥胖糖尿病-严重联合免疫缺陷小鼠后,发展为腺癌。将血浆与培养细胞隔开的膜的显微镜分析证实了血浆中完全没有细胞。我们只观察到直径<0.4 μm 的非细胞颗粒。我们的结果表明,来自癌症患者的血浆能够使培养细胞致癌转化,支持了先前提出的基因组转移假说。